Lex Machina, a leader in legal analytics and a LexisNexis company, unveiled an API Developer Portal.

EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, announced its technology-enabled platform ACTICS by EVERSANA™ was named a 2022 Artificial Intelligence (AI) Award winner.

Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced it acquired Engage, a London-based, award-winning, data and analytics–enabled healthcare marketing firm. 

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company.

As pharmaceutical marketing benefits from soaring advances in data availability and data analyses techniques, brand marketers are called upon to select data and analytics partners. Linda von Rosenvinge, Cross-Disciplined Strategist for Greater Than One (GTO), recommends strategy centers on two towering criteria for these decisions: imagination and agility.

The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the Covid-19 pandemic.

Eli Lilly will add 100 jobs to the company’s manufacturing facilities at the Lilly Technology Center campus in Indianapolis.

W2O – an innovative, analytics-driven, digital-first marketing and communications firm – reported a 23 percent increase in revenue to $177 million in 2018 from $144 million in 2017.

Publicis Health acquired Payer Sciences, an innovative, data-and-analytics-driven health marketing agency focused on helping biopharmaceutical manufacturers navigate the dynamic U.S. reimbursement environment.

Are marketers just paying lip service to the idea that the patient is in charge when it comes to developing patient acquisition and support programs?